Hazard ratios associated with mortality and progression of IPF comparing pirfenidone with no antifibrotic treatment according to diagnostic subgroups (adjusted for age, sex, height, NYHA and FVC at baseline).
收藏Figshare2022-09-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Hazard_ratios_associated_with_mortality_and_progression_of_IPF_comparing_pirfenidone_with_no_antifibrotic_treatment_according_to_diagnostic_subgroups_adjusted_for_age_sex_height_NYHA_and_FVC_at_baseline_/20771888
下载链接
链接失效反馈官方服务：
资源简介：
Hazard ratios associated with mortality and progression of IPF comparing pirfenidone with no antifibrotic treatment according to diagnostic subgroups (adjusted for age, sex, height, NYHA and FVC at baseline).
创建时间：
2022-09-01
